Taiwanese Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Maxigen Biotech

Market Cap: NT$4.0b

Researches, develops, produces, and sells implantable medical devices and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally.

Formosa Pharmaceuticals

Market Cap: NT$4.8b

A clinical stage biopharmaceutical company, engages in developing drug candidates for ophthalmology, oncology, and anti-infectives in Taiwan.

PhytoHealth

Market Cap: NT$3.2b

Researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and dietary supplements in Taiwan.

Eusol BiotechLtd

Market Cap: NT$1.1b

Focuses on research and development of new biotech drugs for sleep disorders.

TCM Biotech International

Market Cap: NT$3.3b

A biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases.

HeXun Biosciences

Market Cap: NT$3.7b

Engages in the research and development of stem cell and treatments in Taiwan.

Advagene Biopharma

Market Cap: NT$1.3b

Engages in the research and development of vaccine technology and related products in Taiwan.

EirGenix

Market Cap: NT$23.2b

Operates as a contract development and manufacturing company in Taiwan and internationally.

Shine-On BioMedicalLtd

Market Cap: NT$3.3b

Research, develops, and manufactures anti-cancer related drug products.

PharmaEngine

Market Cap: NT$15.2b

A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.

Synmosa Biopharma

Market Cap: NT$14.4b

A specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan.

CHO Pharma

Market Cap: NT$11.4b

Engages in research and development of biotechnology in Taiwan.

Savior Lifetec

Market Cap: NT$6.5b

A specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations.

BIONET Therapeutics

Market Cap: NT$3.7b

A biopharmaceutical company, develops cell therapy products and drug development for acute and severe diseases.

ScinoPharm Taiwan

Market Cap: NT$17.9b

Research and develops, produces, and sells active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, rest of Asia, Europe, India, the United States and internationally.

Sinew Pharma

Market Cap: NT$3.5b

A biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases.

Oneness Biotech

Market Cap: NT$34.4b

Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products primarily in Taiwan.

Ever Supreme Bio Technology

Market Cap: NT$14.6b

Engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells.

Alar Pharmaceuticals

Market Cap: NT$9.8b

A drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan.

TaiwanJ Pharmaceuticals

Market Cap: NT$726.7m

A specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan.

Lukas Biomedical

Market Cap: NT$1.1b

Engages in the wholesale and retail of cosmetics in Taiwan.

Standard Chemical & Pharmaceutical

Market Cap: NT$11.3b

Standard Chemical & Pharmaceutical Co. Ltd.

PharmaEssentia

Market Cap: NT$186.5b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

BRIM Biotechnology

Market Cap: NT$3.7b

A clinical-stage company, engages in the development of novel regenerative therapies to combat and cure ophthalmology and degenerative joint diseases.

TaiRx

Market Cap: NT$3.0b

Focuses on the development and commercialization of therapeutics for the treatment of cancer and other diseases.

Vectorite Biomedical

Market Cap: NT$595.3m

Engages in the research and development of biotechnology in Taiwan and internationally.

Senhwa Biosciences

Market Cap: NT$3.7b

A drug development company, engages in the development of new drugs and targeted agents.

GlycoNex Incorporation

Market Cap: NT$2.6b

Engages in the development of cancer drugs using glycosphingolipid antigen and human monoclonal antibody technologies in Taiwan.

Pharmosa Biopharm

Market Cap: NT$7.0b

A biotechnology company, focuses on developing drugs in Taiwan.

Medigen Vaccine Biologics

Market Cap: NT$17.7b

A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.

DV Biomed

Market Cap: NT$1.4b

Manufactures and sells medical-grade skin care products in Taiwan and China.

Abnova (Taiwan)

Market Cap: NT$1.8b

Manufactures and sells various recombinant proteins and antibodies.

Lumosa Therapeutics

Market Cap: NT$34.5b

A clinical-stage pharmaceutical company, develops therapies and solutions for neurological and oncological diseases in Taiwan, Asia, the Americas, and Europe.

UnicoCell Biomed

Market Cap: NT$4.1b

Engages in the research and development of stem cell drugs, cell therapy technology, and regenerative medical services in Taiwan.

YungShin Global Holding

Market Cap: NT$15.0b

Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics in Taiwan, the United States, Mainland China, and Japan.

SynCore BiotechnologyLtd

Market Cap: NT$1.2b

Engages in development and sale of food advisory, medicine inspection, and biotechnology service in Taiwan.